Evidence collection guide for medicinal products to prevent or treat COVID-19

June 2020

Working in collaboration, NICE and NIHR have produced advice on clinical evidence generation for developers of medicinal products to prevent or treat COVID 19.

This guide should be read in conjunction with relevant regulatory guidance documents and theĀ NICE guide to the methods of technology appraisals 2013. Clinical studies do not have to conform to this advice in order to be evaluated by NICE.

This guide will be regularly updated, so for the latest information please click here.

Download a PDF version of this guide for evidence collection.